Highlights Inari Medical, Inc.

Equities

NARI

US45332Y1091

Real-time Estimate Cboe BZX Other stock markets 02:04:08 2024-04-29 pm EDT			5-day change	1st Jan Change
38.59 ^USD	+0.44%		+1.54%	-40.67%

Apr. 02	Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	CI
Apr. 01	Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600	Mar. 26	MT
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry	Mar. 12	CI
Inari Medical Q4 Loss Narrows as Sales Increase -- Shares Decline Premarket	Feb. 29	MT
Earnings Flash (NARI) INARI MEDICAL Reports Q4 Revenue $132.1M, vs. Street Est of $132.1M	Feb. 28	MT
Inari Medical, Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 28	CI
Inari Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Inari Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Inari Medical Reports Higher Q4, 2023 Preliminary Revenue; Provides 2024 Revenue Outlook	Jan. 09	MT
Inari Medical, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Full Year of 2023 and 2024	Jan. 09	CI
Inari Medical, Inc. Announces the First Patient Enrollment in the PEERLESS II Study	Nov. 27	CI
Inari Medical Closes LimFlow Acquisition	Nov. 15	MT
Inari Medical, Inc. completed the acquisition of LimFlow SA.	Nov. 14	CI
Inari Medical Swings to Profit in Q3, Ups 2023 Revenue Guidance, to Buy LimFlow	Nov. 01	MT
Earnings Flash (NARI) INARI MEDICAL Posts Q3 Revenue $126.4M, vs. Street Est of $122M	Nov. 01	MT
Inari Medical, Inc. Revises Revenue Guidance for the Year 2023	Nov. 01	CI
Inari Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Inari Medical, Inc. agreed to acquire LimFlow SA for $415 million.	Oct. 31	CI
Inari Medical, Inc. Raises Revenue Guidance for the Full Year 2023	23-08-02	CI
Earnings Flash (NARI) INARI MEDICAL Reports Q2 Revenue $119M, vs. Street Est of $116.7M	23-08-02	MT
Inari Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Inari Medical, Inc.

Equities

NARI

US45332Y1091

Highlights

Filters